Lung cancer, Non small cell lung cancer (NSCLC), Pancreatic cancer
Results
Phase 2
This trial was done to see if bimagrumab (BYM338) could help stop extreme loss of weight and muscle mass (cachexia). It was for people with advanced non small cell lung cancer (NSCLC) or pancreatic cancer.
The trial was open for people to join between 2011 and 2014, and the team analysed the results in 2014.
Recruitment start: 19 February 2012
Recruitment end: 6 November 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Ken Fearon
Novartis
Last reviewed: 28 March 2022
CRUK internal database number: 9325
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
